Home � Products & Services � Benchmarking Reports � Medical Affairs � Launch Optimization

Building More Effective Medical Affairs Product Launch Teams: Infectious Diseases Segment

Download FREE Excerpt

ID: POP-389

Features:

12 Info Graphics

32 Data Graphics

650+ Metrics

18 Narratives

Pages: 56

Published: 2024

Delivery Format: Shipped

License Options:
$6000 - 1 user
$18000 - Up to 5 users
$30000 - Up to 20 users

Buy Now

919-403-0251

Schedule a Meeting

STUDY OVERVIEW
BENCHMARK CLASS
STUDY SNAPSHOT
KEY FINDINGS
VIEW TOC AND LIST OF EXHIBITS

Medical Affairs teams need to be agile and responsive in launching infectious disease treatments that meet evolving population health needs or public health crises. Their role is pivotal in addressing urgent clinical needs while aligning with broader public health priorities.

Best Practices, LLC conducted this benchmarking research to examine the evolving role of Medical Affairs in infectious diseases product launches, focusing on shifting responsibilities, cross-functional collaboration, performance metrics, resourcing, effectiveness of activities, launch timelines, and the use of digital tools. The report also highlights key success factors and challenges critical to achieving launch excellence in the infectious disease segment.

Industries Profiled:
Pharmaceutical; Diagnostic; Academic; Research; Health Care; Biopharmaceutical; Consulting; Biotech; Medical Device

Companies Profiled:
AstraZeneca; bioMerieux; Boehringer Ingelheim; Cardinal Health; Cipla; Duke University and Health System; Eurofarma; GlaxoSmithKline ; Labaid Group; Matinas BioPharma; MEDiSTRAVA; Melinta Therapeutics; Inc; Pfizer; Terumo BCT: Terumo Blood and Cell Technologies

Study Snapshot

Best Practices, LLC engaged 17 Medical leaders from 14 leading life sciences companies in this benchmarking research study. Medical Directors and upper management executives represent nearly four-fifths of the leaders who shared data and insights on Medical launch activities in this study.

Key topics covered in this report include:

Medical Leadership Roles and Launch Activity Effectiveness in Infectious Diseases Segment
Ensuring Cross-functional Alignment and Collaboration in Infectious Disease Product Launches
Medical Launch Evolution in Infectious Diseases Segment
Infectious Disease Launch Activities Timeline, Performance Tracking, and Resourcing
Critical Success Factors and Major Pitfalls for Medical Affairs During Infectious Disease Product Launches
Digital Launch Implementation and Impact in Infectious Diseases Segment
Launch Tool Deployment for Infectious Disease Products

Key Findings

Select key insights uncovered from this report are noted below. Detailed findings are available in the full report.

Launch Activity Effectiveness: In the infectious diseases segment, Medical Affairs drives launch success, especially through education and support. Notably, 82% of teams lead educational initiatives, with 84% rating them effective. However, only 58% lead Communication and Data Dissemination efforts, despite a 66% effectiveness rate. Organizational Support activities are led by just 45%, though 74% deem them effective. Similarly, Research leadership stands at 45%, with 77% finding it effective. These figures underscore the need for greater leadership in research and support to enhance launch impact in infectious diseases.

Table of Contents

Sr. No.	Topic	Slide No.
I.	Executive Summary	Pg. 4
II.	Section I: Launch Excellence and Medical’s Role & Activity Effectiveness	Pg. 6-12
III.	Section II: Ensuring Cross-functional Alignment and Collaboration	Pg. 13-15
IV.	Section III: Adopting to Ongoing Changes in Medical Landscape	Pg. 16-20
V.	Section IV: Launch Timeline, Preparedness Metrics, and Resourcing	Pg. 21-26
VI.	Section V: Critical Success Factors and Major Pitfalls	Pg. 27-32
VII.	Section VI: Digital Influence on Launch Processes and Launch Tool Deployment	Pg. 33-41
VIII.	Section VII: Participant Demographics	Pg. 42-43
IX.	Section VIII: Detailed Benchmark Study Data	Pg. 44-55
X.	Section IX: About Best Practices, LLC	Pg. 56

List of Charts & Exhibits

I. Launch Excellence and Medical’s Role & Activity Effectiveness

Medical launch excellence framework
Medical Affairs’ role in infectious disease product launches
Medical leadership roles in infectious disease product launches
Medical Affairs’ effectiveness in infectious disease product launch activities
Most effective launch activities for Medical Affairs in infectious diseases segment
Improvement opportunities for Medical Affairs around infectious disease product launch activities

II. Ensuring Cross-functional Alignment and Collaboration

Medical Affairs’ work with internal colleagues to ensure successful infectious disease product launches
Role of Medical Affairs group in cross-functional infectious disease product launch teams

III. Adopting to Ongoing Changes in Medical Landscape

Change fronts for Medical launch evolution
Medical Affairs’ launch evolution around digital data dissemination and communication
Medical Affairs’ launch evolution around medical education
Medical Affairs’ launch evolution around organizational support

IV. Launch Timeline, Preparedness Metrics and Resourcing

Medical Affairs’ infectious disease product launch activities timeline
Total annual Medical Affairs launch investment in U.S. dollars and number of FTEs for infectious disease products during each of the years in launch phase
Launch dashboard and information used with the dashboard for infectious disease products
Percentage of total Medical Affairs launch investment allocated to each of the listed Medical Affairs activities
Percentage of total Medical Affairs launch FTEs allocated to each of the listed Medical Affairs activities

V. Critical Success Factors and Major Pitfalls

Critical success factors for Medical Affairs in infectious disease product launches
Areas where advanced team planning is key for infectious disease product launches
Six critical areas for successful Medical Affairs launch readiness in infectious diseases segment
Major pitfalls for Medical Affairs during infectious disease product launches
Six major challenge areas for Medical Affairs during infectious disease product launches

VI. Digital Influence on Launch Processes and Launch Tool Deployment

Post-pandemic digital technology utilization in Medical Affairs during infectious disease product launches
Impact of digital technologies on current and future infectious disease product launch processes
Digital launch tool deployment and impact
Impact of top three digital activities that Medical leads in infectious diseases segment
Impact of digital activities and programs used to support a successful infectious disease product launch
Top digital tools that can bring success to Medical Affairs product launch activities
Fast-growing digital tools that are impacting Medicals’ launch strategy
Example of a valuable digital tool that supports launch activities

VII. Participant Demographics

Geographic responsibility of benchmark partners

VIII. Detailed Benchmark Study Data

Role served by Medical Affairs in infectious disease product launches
Medical Affairs’ launch role effectiveness in infectious diseases segment
Role served by Medical Affairs in planning, research, and education activities in infectious diseases segment
Role served by Medical Affairs in data dissemination and organizational support activities in infectious diseases segment
Role served by Medical Affairs in research activities in infectious diseases segment
Role served by Medical Affairs in education and data dissemination support activities in infectious diseases segment
Role served by Medical Affairs in organizational support activities in infectious diseases segment
Medical Affairs launch activity involvement timeline - Evidence generation and field-based medical activities in infectious diseases segment
Medical Affairs launch activity involvement timeline - Medical information and medical regulatory activities in infectious diseases segment
Medical Affairs launch activity involvement timeline - HEOR activities and medical / scientific communications in infectious diseases segment
Medical Affairs launch activity involvement timeline - Independent medical education and external engagement activities in infectious diseases segment